A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.
about
Chemotherapy for advanced non-small cell lung cancer in the elderly populationMethodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical reviewIncreased risk of high-grade hemorrhage in cancer patients treated with gemcitabine: a meta-analysis of 20 randomized controlled trialsSystemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdatePaclitaxel plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials.Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort study.A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer.Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysisPhase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.Treatment outcomes in elderly with advanced-stage non-small cell lung cancerUpdate in lung cancer and mesothelioma 2009.Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naïve advanced non-small-cell lung cancer in the era of third-generation agents.Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.Recent advances in targeted advanced lung cancer therapy in the elderly.Post-study therapy as a source of confounding in survival analysis of first-line studies in patients with advanced non-small-cell lung cancerComparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.Evaluation of a pharmacology-driven dosing algorithm of 3-weekly paclitaxel using therapeutic drug monitoring: a pharmacokinetic-pharmacodynamic simulation study.Bevacizumab in combination with different platinum-based doublets in the first-line treatment for advanced nonsquamous non-small-cell lung cancer: A network meta-analysis.Dunnett-type inference in the frailty Cox model with covariates
P2860
Q24186466-F4A8FDE0-1E41-4303-A148-1499C5C05B7DQ28068435-802B53F3-91B8-4BDA-B080-58438942D230Q28533753-15B7BF5C-49C4-4BD4-B598-E1D37A3864F1Q30356434-8E0E0520-8594-44AC-A985-4A9A10FB498AQ33404683-270EC17C-6D70-4327-92A5-8EE95B0BEBDFQ34651916-EF316B95-19CF-426B-8650-282A86A1714DQ35557605-11049EAB-54C9-48A3-A561-9416635AF283Q35722493-209D5C4E-B6CD-4B19-B55F-BD3D20089F77Q36927640-A67BE4BA-1A4B-48A6-8F57-32D1ED6A61A7Q37333926-DCBC7F4D-A4C3-4005-978A-398AFCEFA0B7Q37728779-91AB7866-4BF6-4A3A-9E8F-E1CD26FD6EE6Q38032176-C677F666-31EF-49A6-B29B-A5AC54BEE533Q38258744-9A536B0C-A4ED-4AD2-A548-F09A7FBA43E3Q38847914-A1B61D75-AEE7-4EE4-8BF4-94F645A986FBQ40143039-034CB047-963F-414A-B2F2-68B1F27D50BAQ40342327-765B6CFC-97D8-416D-8DA1-012460223DFDQ45126932-B8A5764A-5713-4F49-BE4F-04CE771855B7Q47376469-A836A896-D391-4C43-95B2-0EDBEE516DA2Q47420701-F0D0360C-8F05-4E8D-821F-743B0011609FQ57263869-4E77F5C1-07D4-4103-9E4E-54CC1782498B
P2860
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A randomized, phase III multic ...... ic non-small-cell lung cancer.
@en
A randomized, phase III multic ...... ic non-small-cell lung cancer.
@nl
type
label
A randomized, phase III multic ...... ic non-small-cell lung cancer.
@en
A randomized, phase III multic ...... ic non-small-cell lung cancer.
@nl
prefLabel
A randomized, phase III multic ...... ic non-small-cell lung cancer.
@en
A randomized, phase III multic ...... ic non-small-cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
A randomized, phase III multic ...... ic non-small-cell lung cancer.
@en
P2093
Alpha Oncology Research Network
C K Obasaju
D M Marinucci
H H Gillenwater
K M Rowland
M A Socinski
M J Edelman
R B Catalano
P2860
P304
P356
10.1093/ANNONC/MDP352
P577
2009-10-15T00:00:00Z